Product NDC: | 60758-866 |
Proprietary Name: | BRIMONIDINE TARTRATE |
Non Proprietary Name: | brimonidine tartrate |
Active Ingredient(s): | 2 mg/mL & nbsp; brimonidine tartrate |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60758-866 |
Labeler Name: | Pacific Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020613 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20030410 |
Package NDC: | 60758-866-05 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (60758-866-05) > 5 mL in 1 BOTTLE, DROPPER |
NDC Code | 60758-866-05 |
Proprietary Name | BRIMONIDINE TARTRATE |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (60758-866-05) > 5 mL in 1 BOTTLE, DROPPER |
Product NDC | 60758-866 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | brimonidine tartrate |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20030410 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Pacific Pharma, Inc. |
Substance Name | BRIMONIDINE TARTRATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |